
Sports








Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd.

HÄAGEN-DAZS CELEBRATES FIVE TRAILBLAZING WOMEN AS THE WINNERS OF THE ROSE PROJECT ARE REVEALED
Häagen-Dazs, General Mills

/C O R R E C T I O N -- Newmark Group, Inc./
Newmark Group, Inc.